
A bipartisan bill in Wisconsin aims to make it easier for researchers to treat patients with acute post-traumatic stress disorder with psilocybin, WPR reports. The measure would create a trust fund called the “medicinal psilocybin treatment program” that would be administered by the University of Wisconsin-Madison, which launched a center for studying psychedelics to treat PTSD in 2021. State Sen. Jesse James (R), one of the bill’s sponsors, told WPR that the “federal government has failed us when it comes to marijuana and the… Read more.